MedPath

EchoNous, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:4

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

ECHO-012 Kosmos Bladder Clinical Validation Study

Not Applicable
Completed
Conditions
Bladder Disease
Bladder Retention Volume
Bladder Dysfunction
Bladder Function
First Posted Date
2025-01-27
Last Posted Date
2025-01-27
Lead Sponsor
EchoNous Inc.
Target Recruit Count
146
Registration Number
NCT06792851
Locations
🇺🇸

Rainier Clinical Research Center, Renton, Washington, United States

Kosmos Anatomical Object Labeling and View Identification Pivotal Study

Not Applicable
Completed
Conditions
Pulmonary Disorder
GYN Disorders
Kidney Disorder
Renal Disorder
Spleen Disorder
Cardiac Disorder
Hepatic Disorder
Hepatobiliary Disorders
First Posted Date
2024-06-21
Last Posted Date
2024-06-21
Lead Sponsor
EchoNous Inc.
Target Recruit Count
32
Registration Number
NCT06468787
Locations
🇺🇸

REVIVAL research institute, LLC, Sherman, Texas, United States

OB-GYN Clinical Validation Study

Not Applicable
Completed
Conditions
Obstetric Complication
GYN Disorders
First Posted Date
2024-06-10
Last Posted Date
2024-06-10
Lead Sponsor
EchoNous Inc.
Target Recruit Count
44
Registration Number
NCT06449872
Locations
🇺🇸

EchoNous, Inc., Redmond, Washington, United States

Kosmos Trio and Ejection Fraction Pivotal Study

Completed
Conditions
Cardiac Disease
First Posted Date
2023-09-07
Last Posted Date
2024-05-21
Lead Sponsor
EchoNous Inc.
Target Recruit Count
153
Registration Number
NCT06027164
Locations
🇺🇸

Revival Research Institute LLC, Dearborn, Michigan, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.